Literature DB >> 26881373

Screening for Prediabetes and Type 2 Diabetes Mellitus.

Neda Laiteerapong1, Adam S Cifu1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26881373      PMCID： PMC5530727          DOI： 10.1001/jama.2015.17545

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement.

Authors:  Albert L Siu
Journal:  Ann Intern Med       Date:  2015-10-27       Impact factor: 25.391

2.  Delayed diagnosis of incident type 2 diabetes mellitus in the ARIC study.

Authors:  T Alafia Samuels; David Cohen; Frederick L Brancati; Josef Coresh; W H Linda Kao
Journal:  Am J Manag Care       Date:  2006-12       Impact factor: 2.229

Review 3.  Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force.

Authors:  Shelley Selph; Tracy Dana; Ian Blazina; Christina Bougatsos; Hetal Patel; Roger Chou
Journal:  Ann Intern Med       Date:  2015-06-02       Impact factor: 25.391

4.  Medicare's intensive behavioral therapy for obesity: an exploratory cost-effectiveness analysis.

Authors:  Thomas J Hoerger; Wesley L Crouse; Xiaohui Zhuo; Edward W Gregg; Ann L Albright; Ping Zhang
Journal:  Am J Prev Med       Date:  2015-02-20       Impact factor: 5.043

5.  Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis.

Authors:  D H Morris; K Khunti; F Achana; B Srinivasan; L J Gray; M J Davies; D Webb
Journal:  Diabetologia       Date:  2013-04-13       Impact factor: 10.122

6.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

7.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice.

Authors:  Paul Park; Rebecca K Simmons; A Toby Prevost; Simon J Griffin
Journal:  BMC Public Health       Date:  2008-10-07       Impact factor: 3.295

9.  Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.

Authors:  Guangwei Li; Ping Zhang; Jinping Wang; Yali An; Qiuhong Gong; Edward W Gregg; Wenying Yang; Bo Zhang; Ying Shuai; Jing Hong; Michael M Engelgau; Hui Li; Gojka Roglic; Yinghua Hu; Peter H Bennett
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-03       Impact factor: 32.069
  9 in total
  2 in total

1.  Identification of Newly Diagnosed Diabetes and Prediabetes Using Fasting Plasma Glucose and Urinary Glucose in a Chinese Population: A Multicenter Cross-Sectional Study.

Authors:  Juan Chen; Hai Jian Guo; Shan-Hu Qiu; Wei Li; Xiao-Hang Wang; Min Cai; Bei Wang; Xiao-Ning Li; Zi-Lin Sun
Journal:  Chin Med J (Engl)       Date:  2018-07-20       Impact factor: 2.628

2.  The Impact of COVID-19 on Blood Glucose: A Systematic Review and Meta-Analysis.

Authors:  Juan Chen; Chunhua Wu; Xiaohang Wang; Jiangyi Yu; Zilin Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-05       Impact factor: 5.555
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.